GENTILE, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 10.813
EU - Europa 3.940
AS - Asia 1.395
AF - Africa 77
SA - Sud America 73
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.312
Nazione #
US - Stati Uniti d'America 10.735
IT - Italia 1.764
IN - India 723
CN - Cina 595
UA - Ucraina 468
FI - Finlandia 441
SE - Svezia 441
DE - Germania 235
GB - Regno Unito 130
RO - Romania 118
IE - Irlanda 77
CA - Canada 73
FR - Francia 71
BE - Belgio 64
AR - Argentina 55
TG - Togo 52
SG - Singapore 43
BG - Bulgaria 30
NL - Olanda 23
CH - Svizzera 20
PL - Polonia 17
ZA - Sudafrica 15
ES - Italia 14
CL - Cile 11
RU - Federazione Russa 8
MY - Malesia 7
AU - Australia 6
CZ - Repubblica Ceca 5
EU - Europa 5
IR - Iran 5
RS - Serbia 5
BO - Bolivia 3
BR - Brasile 3
GR - Grecia 3
JP - Giappone 3
MX - Messico 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
BZ - Belize 2
HK - Hong Kong 2
IL - Israele 2
KR - Corea 2
MK - Macedonia 2
MU - Mauritius 2
NG - Nigeria 2
PT - Portogallo 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CM - Camerun 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
IQ - Iraq 1
JO - Giordania 1
KZ - Kazakistan 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
PH - Filippine 1
SA - Arabia Saudita 1
Totale 16.312
Città #
Fairfield 1.672
Chandler 901
Woodbridge 766
Ashburn 692
Houston 567
Seattle 556
Wilmington 546
Cambridge 507
Princeton 456
Ann Arbor 443
Plano 400
Rome 324
Beijing 231
San Paolo di Civitate 206
Jacksonville 203
Dearborn 187
Lawrence 162
Boston 145
Millbury 142
San Diego 125
Andover 110
Des Moines 107
Horia 93
Falls Church 79
Dublin 77
Norwalk 75
Hefei 74
Grafing 71
Milan 62
Brussels 61
Toronto 58
Federal 55
Kunming 52
Lomé 52
Boardman 51
Nanjing 50
Helsinki 39
San Mateo 30
Sofia 30
Naples 27
New York 26
Nanchang 23
Auburn Hills 22
Jinan 22
Guangzhou 18
Southend 17
Paris 15
Los Angeles 14
Indiana 13
Verona 13
Bern 12
Fremont 12
London 12
Bologna 11
Buffalo 11
Fuzhou 11
Muizenberg 11
Catania 10
Chengdu 10
Dallas 9
Laurel 9
Ottawa 9
Phoenix 9
Trento 9
Palermo 8
Pune 8
Redmond 8
Genova 7
Hebei 7
Taranto 7
Torino 7
Baotou 6
Chongqing 6
Edinburgh 6
San Michele al Tagliamento 6
Warsaw 6
Wuhan 6
Zhengzhou 6
Augusta 5
Belgrade 5
Brno 5
Chicago 5
Finale Emilia 5
Florence 5
Naaldwijk 5
Napoli 5
Ningbo 5
Padova 5
Pescara 5
Provo 5
Reggio Calabria 5
San Jose 5
Shanghai 5
Tappahannock 5
Yellow Springs 5
Alcamo 4
Athens 4
Bari 4
Changsha 4
Columbus 4
Totale 11.011
Nome #
Raro caso di tumore adenomatoide multiplo ad origine dalla tunica vaginale del testicolo e dell’epididimo. 642
SIGNIFICATO DELLE LESIONI IPERPLASTICO-PROLIFERATIVE DELL'UROTELIO IN PAZIENTI SOTTOPOSTI A CHEMIOTERAPIA ENDOVESCICALE DOPO TUR O TVR PER CARCINOMA SUPERFICIALE DELLA VESCICA 381
Ureterite cistica: Descrizione di un caso associato a calcolosi renale a stampo bilaterale 231
Encrusted cystitis in an immunocompromised patient: Possible coinfection by Corynebacterium urealyticum and E-coli 144
Premature Ejaculation Results in Female Sexual Distress: Standardization and Validation of a New Diagnostic Tool for Sexual Distress 136
Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®) 133
Il Test di Thomas nelle prostatici 129
2D and 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy with erectile function correlation 120
null 108
Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer 108
Chromogranin A expression in familial versus sporadic prostate cancer 92
Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis 90
Penile subcutaneous fibrolipoma postaugmentative phalloplasty. 90
COMPLETE RESPONSE TO THE COMBINATION THERAPY WITH ANDROGEN BLOCKADE AND SOMATOSTATIN ANALOGUE IN A PATIENT WITH ADVANCED PROSTATE CANCER: MAGNETIC RESONANCE IMAGING WITH 1H-SPECTROSCOPY: Part 2 88
Histopathological aspects of transitional cell carcinoma of the bladder: Analysis of 20 years experience 87
CIRCULATING TUMOR CELLS AND THEIR PROGNOSTICSIGNIFICANCE IN NON MUSCLE INVASIVE BLADDER CANCER:A CELLSEARCH ANALYSIS. 85
In vivo 3D neuroanatomical evaluation of periprostatic nerve plexus with 3T-MR Diffusion Tensor Imaging 85
Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma 84
Knotless "three-U-stitches" technique for urethrovesical anastomosis during laparoscopic radical prostatectomy 84
New anti-angiogenic targeted therapy in advanced renal cell carcinoma (RCC): Current status and future prospects 83
Determinants of erectile dysfunction risk in a large series of Italian men attending andrology clinics 83
Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer 83
Urethral pseudodiverticulum secondary to penile fracture and complete urethra dissection 82
Early recovery of urinary continence after radical prostatectomy using early pelvic floor electric stimulation and biofeedback associated treatment 81
Effect of propionyl-L-carnitine, L-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of erectile dysfunction in diabetes 81
Use of Multiparametric MR with Neurovascular Bundle Evaluation to Optimize the Oncological and Functional Management of Patients Considered for Nerve-Sparing Radical Prostatectomy 80
A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer 80
Recurrent varicocele: Role of antegrade sclerotherapy as first choice treatment 77
Laparoscopic versus open radical prostatectomy in high prostate volume cases: impact on oncological and functional results 77
Risk decrease of intra-operative bleeding during TURP with the uptake of Finasteride: Evaluation of VEGF and CD34. 76
Primary Metastatic Neuroendocrine Small Cell Bladder Cancer: A Case Report and Literature Review 76
Bladder cancer: Innovative approaches beyond the diagnosis 76
A NEW MOLECULAR CHEMOSENSITIVITY TEST TO IMPROVE AND PREDICT EFFICACY OF INTRAVESICAL ADJUVANTTHERAPY IN NMIBC (NON MUSCLE INVASIVE BLADDER CANCER) 75
Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging 75
Prostate-specific antigen increase during dutasteride to indicate the need for prostate biopsy: influence of prostatic inflammation 74
DNA markers in diagnosis of adult dominant polycystic kidney disease. 73
Adjuvant therapy with sorafenib in bone Metastases bilateral renal carcinoma: a case report: Part II 73
Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer 72
Bladder cancer: A simple model becomes complex 72
Geometrical modified Nesbit corporoplasty to correct different types of penile curvature: description of the surgical procedure based on geometrical principles and long-term results 72
Large bowel infarct following antegrade scrotal sclerotherapy for varicocele: A case report. 71
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer 70
Management of Urethral Stent Failure for Recurrent Anterior Urethral Strictures 70
Etoricoxib and intermittent androgen deprivation (IAD) therapy in patients with biochemical progression after radical prostatectomy 70
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: A critical review 70
Early Recovery of Urinary Continence After Radical Prostatectomy Using Early Pelvic Floor Electrical Stimulation and Biofeedback Associated Treatment 70
Anatomia chirurgica della Prostata: cosa deve "vedere" l'imaging. 69
USE OF MULTIPARAMETRIC MR WITH NEUROVASCULAR BUNDLE EVALUATION TO OPTIMIZE THE ONCOLOGICAL AND FUNCTIONAL MANAGEMENT OF PATIENTS CONSIDERED FOR NERVE SPARING RADICAL PROSTATECTOMY 69
Evaluation of an alternative dosing regimen with tadalafil, three times per week, for men with erectile dysfunction: SURE study in Italy 69
Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy 68
Current and emerging strategies in bladder cancer 68
Benign prostatic hyperplasia: What about a campaign for prevention? 68
Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis. 68
Prognostic predictors in prostate cancer cases with biochemical progression after surgery treated with intermittent androgen deprivation (IAD) 67
Pain in the upper anterior-lateral part of the thigh in women affected by endometriosis: study of sensitive neuropathy 67
Neuroendocrine differentiation in human prostate tissue: Is it detectable and treatable? 66
Use of multiparametric MR with neurovascular bundle evaluation to optimize the oncological and functional management of patients considered for nerve sparing radical prostatectomy 66
Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci 66
Untargeted metabolomics of prostate cancer zwitterionic and positively charged compounds in urine 65
Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): Pattern changes from inflammation to prostate cancer 64
Use of inflatable penile prostheses AMS CX with momentary squeeze in a patient with Peyronie's disease after removal of two previously implanted penile prostheses 64
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: Analysis in primary cell cultures of human prostate carcinoma 64
Histopathological aspects associated with the diagnosis of benign prostatic hyperplasia: Clinical implications 63
Can p503s, p504s and p510s gene expression in peripheral-blood be useful as a marker of prostatic cancer? 63
Biopsy-derived gleason artifact and prostate volume: Experience using ten samples in larger prostates 63
Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction 62
Analysis of sperm motility related to transcriptional alterations of mitocondrial genes in males affected by infertility 62
Incidental prostatic stromal tumor of uncertain malignant potential (STUMP): histopathological and immunohistochemical findings. 62
Determination of the time for maximal response to neoadjuvant hormone therapy for prostate cancer using magnetic resonance with spectroscopy (MRSI) and dynamic contrast enhancement (DCEMR) 62
Randomized trial comparing an anterograde versus a retrograde approach to open radical prostatectomy: results in terms of positive margin rate 61
ACP(1) genetic polymorphism and spermatic parameters in men with varicocele 61
Prostate Cancer Gene 3 and Multiparametric Magnetic Resonance Can Reduce Unnecessary Biopsies: Decision Curve Analysis to Evaluate Predictive Models 61
Interstitial cystitis and infectious agents 61
Human Papilloma Virus DNA Detection, p53 and Ki67 Expression in Penile Verrucous and Squamous Cell Carcinomas in the Same Patient 61
Role of proton magnetic resonance spectroscopic and dynamic-enhanced imaging in the detection of local recurrence after radical prostatectomy for prostate cancer 61
Etoricoxib and intermittent androgen deprivation therapy in patients with biochemical progression after radical prostatectomy 60
Recurrent transitional cell carcinoma of the bladder: A mixed nested variant case report and literature review. 60
Chromogranin A and biochemical progression free survival in prostate adenocarcinomas submitted to radical prostatectomy 60
Recovery of urinary continence after radical prostatectomy using early vs late pelvic floor electrical stimulation and biofeedback-associated treatment 60
Intermittent androgen deprivation in prostate cancer cases with biochemical progression after radical prostatectomy: Are we ready to treat? 60
Clinical and pathological features of primary renal synovial sarcoma: analysis of 64 cases from 11 years of medical literature. 60
Current diagnostic procedure on neuroendocrine differentiation of prostate cancer 60
Update on screening in prostate cancer based on recent clinical trials 59
Etoricoxib and intermittent androgen deprivation (IAD) therapy in patients with biochemical progression after radical prostatectomy 59
Priapismo idiopatico: Osservazioni di un caso e revisione della letteratura 59
Plication Surgery for Peyronie's Disease 59
Laparoscopic partial nephrectomy for endophytic hilar tumors: feasibility and outcomes 59
Detection of human papillomavirus DNA, P53 and Ki67 expression in penile carcinomas 59
Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy 59
Reduced intraoperative bleeding during transurethral resection of the prostate: Evaluation of finasteride, vascular endothelial growth factor, and CD34 59
Esperienza a lungo termine con un approccio anatomico anterogrado alla prostatectomia radicale (RRP): risultati in termini di margini chirurgici 58
Two-Sided Bulbar Urethroplasty Using Dorsal Plus Ventral Oral Graft: Urinary and Sexual Outcomes of a New Technique 58
Did men with erectile dysfunction discuss their condition with partner and physicians? A survey of men attending a free call information service 58
Complete response to the combination therapy with androgen blockade and somatostatin analogue in a patient with advanced prostate cancer: Magnetic resonance imaging with 1H-spectroscopy 58
Premature ejaculation: prevalence and associated conditions in a sample of 12,558 men attending the andrology prevention week 2001--a study of the Italian Society of Andrology (SIA). 58
Predictors for response to intermittent androgen deprivation (IAD) in prostate cancer cases with biochemical progression after surgery 58
Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasia 58
Variation of chromogranin a serum levels after radical retropubic prostatectomy for prostate adenocarcinoma 57
Concurrent Spontaneous Umbilical and Abdominal Wall Endometriosis Retracting the Surrounding Cutis 57
Bilateral exvivo repair and kidney autotransplantation for complex renal artery aneurysms: A case report and literature review 57
Totale 8.299
Categoria #
all - tutte 39.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 105
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.558


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.463 0 0 0 0 0 0 0 0 54 292 637 480
2019/20203.650 631 139 66 156 320 534 560 428 327 247 164 78
2020/20211.415 125 152 42 303 23 74 39 190 96 196 125 50
2021/20223.656 23 269 293 173 508 102 71 349 259 385 463 761
2022/20233.370 812 592 157 323 321 393 56 172 318 27 138 61
2023/2024956 167 229 62 131 159 86 49 57 16 0 0 0
Totale 16.611